Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Approvable letter for Cialis in erectile dysfunction

May 2, 2002

Chinese herbal medicine improves I/R injury to the kidney via activation of eNOS

April 30, 2002

Pan-caspase inhibitor protects against renal ischemia/reperfusion injury

April 26, 2002

Alpha1B-adrenoceptor antagonists for the treatment of urinary tract disorders

April 25, 2002

Japanese researchers report new preclinical data on the 5alpha-reductase inhibitor TF-505

April 19, 2002

SSRIs discovered at Pfizer claimed specifically for premature ejaculation

April 16, 2002

Committee recommends approval of Cozaar to delay renal disease in type 2 diabetics

April 16, 2002

InterMune licenses pirfenidone for fibrotic diseases

April 10, 2002

First patients receive TA-1790 in ED study

April 8, 2002

Positive phase IIa results achieved by HCT-1026 in overactive bladder

April 2, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...